Results 31 to 40 of about 476,350 (261)
Australian Journal of General Practice, 2021 COVID-19 has been at the forefront of public and scientific attention since the initial report in December 2019. The kidney is one of the target organs of the causative SARS-CoV-2 virus.The aim of this article is to discuss the current understanding of COVID-19 renal disease from a primary care perspective, with the caveat that our knowledge of the ...
Titus, Thomas, Rahman, Atifur
openaire +4 more sources
Bronchiolitis and SARS-CoV-2 [PDF]
Archives of Disease in Childhood, 2021 BackgroundIt has been speculated that the SARS-CoV-2 was already widespread in western countries before February 2020.MethodsWe gauged this hypothesis by analysing the nasal swab of infants with either bronchiolitis or a non-infectious disease admitted to the Ospedale Maggiore, Milan (one of the first epicentres of SARS-CoV-2 outbreak in Europe) from ...
Milani, Gregorio Paolo +10 more
openaire +2 more sources
Guillain‐Barré syndrome after SARS‐CoV‐2 infection
Journal of General and Family Medicine, 2022 We herein report a case of Guillain‐Barré syndrome (GBS) after SARS‐CoV‐2 infection. The patient was a close contact with a SARS‐CoV‐2 patient. Initially, she did not have any symptoms and quarantined at a hotel.
Mikiya Kajita +5 more
doaj +1 more source
Erythema Multiforme Major following SARS‐CoV‐2 vaccine
Clinical Case Reports, 2021 Erythema multiforme major, an immune‐mediated skin reaction to infections or medications with oral involvement, should be taken into account as a potential side effect of several vaccines, including SARS‐CoV‐2.
Alberto Maria Saibene +7 more
doaj +1 more source
SARS‐CoV‐2 infection with bilateral intralabyrinthine hemorrhage
Clinical Case Reports, 2022 A 47‐year‐old woman presented with the complaint of sudden hearing loss associated with vertigo. Serological testing was positive for IgM and negative for IgG COVID‐19 antibodies, with no other associated factors.
Vagner Antonio Rodrigues daSilva +6 more
doaj +1 more source
SARS CoV- 2 vaccination induces antibodies against cardiolipin
BMC Research Notes, 2022 Objective Cases of thrombosis have been reported after administration of SARS-CoV-2 vaccines, with controversial results relating to Oxford-AstraZeneca’s ChAdOx1-S.
George Krashias +5 more
doaj +1 more source
SARS‐CoV‐2 Omicron variant: Characteristics and prevention
MedComm, 2021 Coronavirus disease 2019 (COVID‐19) has brought about a great threat to global public health. Recently, a new severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) variant B.1.1.529 has been reported in South Africa and induced a rapid increase in
Xuemei He +4 more
doaj +1 more source
Infection Prevention in PracticeSummary: Background: During the SARS-CoV-2 pandemic, dominant viral variants were repeatedly replaced by new variants with altered properties, frequently changing the dynamics of the infection event, as well as the effectiveness of vaccines and ...
Hanno Schmidt +11 more
doaj +1 more source
Monitoring of SARS‐CoV‐2 infection in mustelids
EFSA Journal, 2021 American mink and ferret are highly susceptible to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), but no information is available for other mustelid species.
European Food Safety Authority and European Centre for Disease Prevention and Control +14 more
doaj +1 more source
eLife, 2022 A new study sheds light on how SARS-CoV-2 influences the way natural killer cells can recognize and kill infected cells.
Paola Kučan Brlić, Ilija Brizić
openaire +5 more sources